Matinas BioPharma Holdings, Inc. SEC filings MTNB

Matinas BioPharma Holdings, Inc. has 570 filings in SEC EDGAR's recent list, going back to Jul 25, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on December 31.

Matinas BioPharma Holdings, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Nov 3, 2026 Nov 3, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 28, 2026 Sep 25, 2026
8-K Current report
Other events
Sep 16, 2026 Sep 16, 2026
8-K Current report
Listing notice, Other events
Sep 4, 2026 Aug 31, 2026
8-K Current report
Agreement ended
Jul 24, 2026 Jul 23, 2026
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Jul 13, 2026 Jul 10, 2026
8-K Current report
Listing notice, Other events
Jun 26, 2026 Jun 24, 2026
8-K Current report
Listing notice
Apr 3, 2026 Apr 2, 2026
8-K Current report
Officer or director change
Jan 23, 2026 Jan 22, 2026
8-K Current report
Officer or director change
Dec 12, 2025 Dec 12, 2025
8-K Current report
Officer or director change
Nov 21, 2025 Nov 18, 2025
8-K Current report
Material agreement, Unregistered share sale
Aug 18, 2025 Aug 15, 2025
8-K Current report
Bylaw or fiscal year change
Aug 6, 2025 Aug 6, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 23, 2025 Jun 23, 2025
8-K Current report
Change to shareholder rights, Officer or director change, Other events
May 2, 2025 Apr 30, 2025
8-K Current report
Unregistered share sale, Other events
Apr 8, 2025 Apr 8, 2025
8-K Current report
Shareholder vote results
Apr 4, 2025 Apr 4, 2025
8-K Current report
Officer or director change
Mar 14, 2025 Mar 13, 2025
8-K Current report
Officer or director change, Other events
Mar 11, 2025 Mar 11, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
Feb 13, 2025 Feb 13, 2025
8-K Current report
Officer or director change
Feb 11, 2025 Feb 5, 2025
8-K Current report
Officer or director change, Other events
Feb 7, 2025 Feb 5, 2025
8-K Current report
Officer or director change
Jan 24, 2025 Jan 21, 2025
8-K Current report
Listing notice
Jan 10, 2025 Jan 6, 2025
8-K Current report
Officer or director change
Nov 27, 2024 Nov 27, 2024
8-K Current report
Exit or restructuring costs, Impairment, Officer or director change, Regulation FD disclosure, Other events
Oct 31, 2024 Oct 31, 2024
8-K Current report
Officer or director change
Oct 24, 2024 Oct 23, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 3, 2024 Aug 30, 2024
8-K Current report
Other events
Aug 28, 2024 Aug 27, 2024
8-K Current report
Other events
Aug 20, 2024 Aug 20, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2024 Aug 14, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Apr 5, 2024 Apr 2, 2024
8-K Current report
Regulation FD disclosure
Mar 28, 2024 Mar 28, 2024
8-K Current report
Results of operations
Mar 27, 2024 Mar 27, 2024
8-K Current report
Regulation FD disclosure, Other events
Mar 25, 2024 Mar 25, 2024
8-K Current report
Regulation FD disclosure, Other events
Mar 22, 2024 Mar 22, 2024
8-K Current report
Other events
Mar 22, 2024 Mar 22, 2024
8-K Current report
Regulation FD disclosure, Other events
Feb 26, 2024 Feb 26, 2024
8-K Current report
Regulation FD disclosure, Other events
Feb 20, 2024 Feb 20, 2024
8-K Current report
Regulation FD disclosure
Jan 9, 2024 Jan 9, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 27, 2023 Dec 27, 2023
8-K Current report
Regulation FD disclosure, Other events
Dec 21, 2023 Dec 21, 2023
8-K Current report
Regulation FD disclosure
Nov 20, 2023 Nov 20, 2023
8-K Current report
Regulation FD disclosure, Other events
Nov 9, 2023 Nov 7, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Shareholder vote results
Nov 2, 2023 Nov 1, 2023
8-K Current report
Listing notice, Other events
Sep 22, 2023 Sep 21, 2023
8-K Current report
Regulation FD disclosure
Sep 20, 2023 Sep 20, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Results of operations, Regulation FD disclosure, Other events
May 10, 2023 May 10, 2023
8-K Current report
Regulation FD disclosure, Other events
Apr 18, 2023 Apr 18, 2023
8-K Current report
Results of operations
Mar 15, 2023 Mar 15, 2023
8-K Current report
Regulation FD disclosure, Other events
Jan 30, 2023 Jan 30, 2023
8-K Current report
Regulation FD disclosure, Other events
Jan 12, 2023 Jan 12, 2023
8-K Current report
Regulation FD disclosure
Dec 29, 2022 Dec 29, 2022
8-K Current report
Shareholder vote results
Nov 14, 2022 Nov 14, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2022 Nov 2, 2022
8-K Current report
Regulation FD disclosure, Other events
Oct 21, 2022 Oct 21, 2022
8-K Current report
Regulation FD disclosure
Sep 13, 2022 Sep 13, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 12, 2022 May 12, 2022
8-K Current report
Regulation FD disclosure
Apr 13, 2022 Apr 13, 2022
8-K Current report
Regulation FD disclosure, Other events
Apr 11, 2022 Apr 11, 2022
8-K Current report
Results of operations
Mar 8, 2022 Mar 8, 2022
8-K Current report
Regulation FD disclosure, Other events
Jan 25, 2022 Jan 25, 2022
8-K Current report
Regulation FD disclosure, Other events
Dec 16, 2021 Dec 16, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 6, 2021 Dec 6, 2021
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
8-K Current report
Shareholder vote results
Nov 1, 2021 Nov 1, 2021
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Sep 20, 2021 Sep 17, 2021
8-K Current report
Regulation FD disclosure, Other events
Sep 13, 2021 Sep 13, 2021
8-K Current report
Results of operations
Aug 10, 2021 Aug 10, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
8-K Current report
Results of operations
Mar 29, 2021 Mar 29, 2021
8-K Current report
Regulation FD disclosure, Other events
Feb 1, 2021 Feb 1, 2021
8-K Current report
Shareholder vote results
Jan 27, 2021 Jan 26, 2021
8-K Current report
Regulation FD disclosure
Jan 14, 2021 Jan 14, 2021
8-K Current report
Other events
Dec 28, 2020 Dec 28, 2020
8-K Current report
Regulation FD disclosure, Other events
Dec 8, 2020 Dec 7, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 1, 2020 Dec 1, 2020
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Nov 25, 2020 Nov 19, 2020
8-K Current report
Results of operations
Nov 6, 2020 Nov 6, 2020
8-K Current report
Shareholder vote results
Nov 4, 2020 Nov 2, 2020
8-K Current report
Regulation FD disclosure, Other events
Oct 19, 2020 Oct 19, 2020
8-K Current report
Officer or director change, Other events
Sep 15, 2020 Sep 11, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
8-K Current report
Material agreement
Jul 2, 2020 Jul 2, 2020
8-K Current report
Regulation FD disclosure
Jun 2, 2020 Jun 2, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
8-K Current report
Results of operations
Mar 9, 2020 Mar 9, 2020
8-K Current report
Agreement ended
Feb 20, 2020 Feb 19, 2020
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jan 10, 2020 Jan 9, 2020
8-K Current report
Shareholder vote results
Nov 1, 2019 Nov 1, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2019 Aug 13, 2019
8-K Current report
Results of operations
May 14, 2019 May 14, 2019
8-K Current report
Results of operations
Apr 2, 2019 Apr 2, 2019
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Mar 15, 2019 Mar 15, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 25, 2019 Feb 22, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 3, 2019 Dec 31, 2018
8-K Current report
Shareholder vote results
Nov 2, 2018 Nov 1, 2018
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 15, 2018 Oct 15, 2018
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 6, 2018 Sep 5, 2018
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jun 19, 2018 Jun 19, 2018
8-K Current report
Officer or director change
Jun 18, 2018 Jun 14, 2018
8-K Current report
Other events
May 25, 2018 May 25, 2018
8-K Current report
Officer or director change
Mar 27, 2018 Mar 22, 2018
8-K Current report
Other events
Jan 8, 2018 Jan 8, 2018
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 14, 2017 Dec 13, 2017
8-K Current report
Shareholder vote results
Oct 26, 2017 Oct 25, 2017
8-K Current report
Regulation FD disclosure
Aug 10, 2017 Aug 10, 2017
8-K Current report
Results of operations
Aug 8, 2017 Aug 8, 2017
8-K/A Amended current report
Regulation FD disclosure, Other events
Jun 26, 2017 Jun 26, 2017
8-K Current report
Regulation FD disclosure
Jun 26, 2017 Jun 26, 2017
8-K Current report
Regulation FD disclosure
Jun 5, 2017 Jun 3, 2017
8-K Current report
Material agreement
Apr 28, 2017 Apr 28, 2017
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 18, 2017 Apr 18, 2017
8-K Current report
Results of operations, Regulation FD disclosure
Apr 3, 2017 Apr 3, 2017
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 30, 2017 Mar 30, 2017
8-K Current report
Unregistered share sale, Regulation FD disclosure
Jan 19, 2017 Jan 13, 2017
8-K Current report
Material agreement, New debt
Dec 21, 2016 Dec 15, 2016
8-K Current report
Officer or director change, Shareholder vote results
Oct 13, 2016 Oct 7, 2016
8-K Current report
Regulation FD disclosure
Oct 6, 2016 Oct 6, 2016
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 13, 2016 Sep 12, 2016
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Aug 1, 2016 Jul 26, 2016
8-K Current report
Officer or director change
Mar 9, 2016 Mar 7, 2016
8-K Current report
Shareholder vote results
Nov 5, 2015 Oct 29, 2015
8-K Current report
Officer or director change
Oct 1, 2015 Sep 29, 2015
8-K Current report
Regulation FD disclosure
Sep 9, 2015 Sep 9, 2015
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 1, 2015 Sep 1, 2015
8-K Current report
Other events
Aug 18, 2015 Aug 18, 2015
8-K Current report
Material agreement, Unregistered share sale
Apr 10, 2015 Apr 10, 2015
8-K Current report
Material agreement, Unregistered share sale
Apr 6, 2015 Mar 31, 2015
8-K/A Amended current report
Acquisition or sale of assets, Results of operations
Mar 19, 2015 Jan 29, 2015
8-K Current report
Officer or director change
Mar 18, 2015 Mar 12, 2015
8-K Current report
Regulation FD disclosure
Feb 2, 2015 Feb 2, 2015
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Jan 30, 2015 Jan 29, 2015
8-K Current report
Other events
Dec 23, 2014 Dec 23, 2014
8-K Current report
Regulation FD disclosure
Aug 8, 2014 Aug 8, 2014
8-K Current report
Regulation FD disclosure
Apr 30, 2014 Apr 30, 2014

Showing 140 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MTNB (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bedminster, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1582554

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.